Shareholders approve 108,612-share increase to Dogwood equity incentive plan at annual meeting

Dogwood Therapeutics, Inc.

Plan amendment raises shares reserved from 82,500 to 191,112; approved with 275,020 for, 6,482 against, 1,284 abstain.
Seven directors elected: De La Rosa, Duncan, Keefer, Thomas, Toh, Whitley, Yu. No director changes announced.
Ratification of Forvis Mazars as auditor for FY2025: 888,808 for, 31,671 against, 1,116 abstain.
Annual meeting quorum: 921,595 shares (48.22% voting power).
Amendment includes one-year minimum vesting for future grants, with limited exception for new hires.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.